| Vaginal expulsion of submucosal fibroids after uterine artery embolization. A report of three cases. | |
| | |
MedLine Citation:
|
PMID: 10319310 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Since October 1996, at our fibroid center, we have been using the uterine artery embolization (UAE) procedure as a nonsurgical means to treat patients with fibroids and menorrhagia. We have performed this procedure on over 180 patients, 3 of whom experienced vaginal expulsion of submucosal fibroids from two to seven months later. CASES: A 37-year-old woman underwent UAE in November 1997 and expelled five submucosal fibroids two to three months later. A 43-year-old woman underwent UAE in August 1997 and expelled a submucosal fibroid four months later. A 46-year-old woman underwent UAE in April 1997 and expelled a submucosal fibroid seven months later. CONCLUSION: The use of UAE to treat patients with fibroids and menorrhagia is relatively new. Our experience has revealed that a significant percentage of patients who have had the embolization procedure will have reduction in menorrhagia and also in the volume of their fibroids. Complications and side effects have been few. Vaginal expulsion of submucosal fibroids can be viewed as a side effect of the procedure, and, to the best of our knowledge, these are the first reported cases of this postembolization occurrence. |
| | |
Authors:
|
R P Berkowitz; F L Hutchins; R L Worthington-Kirsch |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: The Journal of reproductive medicine Volume: 44 ISSN: 0024-7758 ISO Abbreviation: J Reprod Med Publication Date: 1999 Apr |
Date Detail:
|
Created Date: 1999-06-29 Completed Date: 1999-06-29 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 0173343 Medline TA: J Reprod Med Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 373-6 Citation Subset: IM |
Affiliation:
|
Philadelphia Fibroid Center, Pennsylvania 19004, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Antineoplastic Agents, Hormonal / therapeutic use Combined Modality Therapy Embolization, Therapeutic* Female Humans Leiomyoma / complications, diagnosis, therapy* Leuprolide / therapeutic use Menorrhagia / etiology Middle Aged Treatment Outcome Uterine Neoplasms / complications, diagnosis, therapy* |
| Chemical | |
Reg. No./Substance:
|
0/Antineoplastic Agents, Hormonal; 53714-56-0/Leuprolide |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Status epilepticus during pregnancy. A case report.
Next Document: Severe nonimmune hydrops fetalis and congenital corneal opacification secondary to human parvovirus ...